ETON Latest Headlines

Eton’s ET-700 pilot study shows fewer GI side effects than GALZIN, setting up a 2027 formulation push

Market Chameleon (Fri, 6-Nov 9:53 AM)

Eton Pharmaceuticals Earnings Call Highlights Record Growth

at www.tipranks.com (Fri, 6-Nov 7:29 PM)

Eton Pharma jumps after Q3 beat and guidance hike

at seekingalpha.com (Fri, 6-Nov 9:04 AM)

At a glance: stocks gapping up premarket

at seekingalpha.com (Fri, 6-Nov 6:50 AM)

Eton Pharmaceuticals Reports Preliminary ET-700 Study Results

at www.tipranks.com (Thu, 5-Nov 5:11 PM)

Eton Pharmaceuticals Non-GAAP EPS of $0.50 beats by $0.13, revenue of $57.9M beats by $15.69M

at seekingalpha.com (Thu, 5-Nov 4:35 PM)

Canaccord Genuity Remains a Buy on Eton Pharmaceuticals (ETON)

at www.tipranks.com (Tue, 3-Nov 7:55 AM)

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), BioMarin Pharmaceutical (BMRN) and Eton Pharmaceuticals (ETON)

at www.tipranks.com (Tue, 3-Nov 7:41 AM)

Eton Announces ET-900 Program for Infantile Spasms

at www.tipranks.com (Mon, 2-Nov 7:27 AM)

Record Revenue and Higher Guidance Highlight Eton Pharmaceuticals’ Standout Quarter

Market Chameleon (Fri, 14-Aug 10:30 AM)

Eton Pharmaceuticals Doubles Revenue and Raises Guidance Amid Strong Rare Disease Portfolio Performance

Market Chameleon (Fri, 14-Aug 7:27 AM)